FitPeo frames Ozempic, Zepbound and other GLP-1s as a useful tool rather than a fix, and stresses pairing them with solid eating habits.
Recap by typeshit. Post by @fitpeoinc on Instagram.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Novo plans oral Wegovy in France in November, and J.P. Morgan expects third-quarter sales around DKK 76 billion, about 4% above consensus. US scripts dipped for oral Wegovy and Foundayo.
Tino Bourse points to new Wegovy data showing a large cut in liver fat in patients with obesity, plus continued oral version results, as possible good news for Novo stock.
Loading…